buPROPion Hydrochloride Extended-release Tablets, USP (SR), 200 mg, 60 count bottles, Rx only, Di...

FDA Recall #D-0446-2017 — Class III — December 20, 2016

Recall #D-0446-2017 Date: December 20, 2016 Classification: Class III Status: Terminated

Product Description

buPROPion Hydrochloride Extended-release Tablets, USP (SR), 200 mg, 60 count bottles, Rx only, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Ind. Ltd., Halol-Baroda Highway, Halol-389 350, Gujarat, India NDC 47335-0738-86

Reason for Recall

Failed Dissolution Specifications; 18 month stability time point

Recalling Firm

Sun Pharmaceutical Industries, Inc. — Cranbury, NJ

Classification

Class III — Not likely to cause adverse health consequences.

Product Type

Drugs

Product Quantity

11,618 bottles

Distribution

Nationwide

Code Information

JKP0905A 04/17

Status

Terminated

Voluntary / Mandated

Voluntary: Firm initiated